Login to Your Account



Pharma: Other News To Note


Wednesday, December 4, 2013
• Protagen AG, of Dortmund, Germany, said it signed a collaboration agreement with Pfizer Inc., of New York, for the use of its Serotag technology to discover predictive or patient stratification markers for a drug in development by Pfizer.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription